Bringing the GFF to the 34th Executive Committee Meeting

November 4, 2020
Online

As a part of the 34th meeting of the Executive Committee on Global Health and Human Security, Dr. Muhammad Pate, Director of the Global Financing Facility for Women, Children and Adolescents (GFF) spoke to over 50 meeting participants, including legislators, senior government officials, academia, private companies, and civil society organizations in Japan. He explained the critical role of the GFF under the current pandemic, alerting the committee members on how the essential services for mothers, children and adolescents have been undermined significantly, and called for the continued support from Japan.

Opening
Akio Okawara, President and CEO, Japan Center for International Exchange (JCIE); Director of the Executive Committee on Global Health and Human Security (EC)

Opening remarks
Keizo Takemi, Member, House of Councillors; Senior Fellow, JCIE; Chair of EC

Report on recommendations by the Special Commission on Japan’s Strategy on Development Assistance for Health (DAH)
Yasuhisa Shiozaki, Member, House of Representatives; former Minister for Health, Labour and Welfare; Chair, Special Commission on Japan’s Strategy on DAH

Discussions

Special Session 
Dr. Muhammad Ali Pate, Global Director, Health, Nutrition and Population (HNP) Global Practice, the World Bank Group; Director, Global Financing Facility for Women, Children and Adolescents (GFF)

Guest:

Muhammad Pate, Global Director, Health, Nutrition and Population (HNP) Global Practice of the World Bank; Director, Global Financing Facility for Women, Children and Adolescents (GFF)


Chair: 

Keizo Takemi, Member, House of Councillors (LDP); Senior Fellow, Japan Center for International Exchange (JCIE)


Director:

Akio Okawara, President and CEO, JCIE


Senior Advisors:

(alphabetical order)

Ichiro Aisawa, Member, House of Representatives (LDP)

Katsunobu Kato, Chief Cabinet Secretary; Member, House of Representatives (LDP)

Yasuhisa Shiozaki, Member, House of Representatives (LDP)

Norihisa Tamura, Minister of Health, Labour and Welfare; Member, House of Representatives (LDP)


Members:

(alphabetical order)

Yasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Yasumasa Fukushima, Medical Commissioner, Ministry of Health, Labour and Welfare

Motohisa Furukawa, Member, House of Representatives (LDP)

Noriko Furuya, Member, House of Representatives (Komeito)

Haruhiko Hirate, President, Hirate & Associates

Masaki Inaba, Representative, Japan CSO Network on Global Health; Policy Advisor, Japan Civil Society Network on SDGs (SDGs Japan)

Sumie Ishii, Chairperson, JOICFP (Japanese Organization for International Cooperation in Family Planning)

Hiroto Izumi, Special Advisor to Prime Minister

Masamine Jimba, Professor and Chair, Department of Community and Global Health, Graduate School of Medicine, University of Tokyo

Masahiro Kajio, Councillor, Director-General, Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat

Yasushi Katsuma, Professor, International Studies Program, Graduate School of Asia-Pacific Studies (GSAPS); Head of Global Health Affairs & Governance Group, Institute for Global Health Policy (iGHP), National Center for Global Health & Medicine (NCGM)

 Nobuko Kayashima, Senior Vice President, Japan International Cooperation Agency (JICA)

Kiyoshi Kodera, Chair of the Board, Water Aid Japan

Norihiro Kokudo, President, National Center for Global Health and Medicine (NCGM)

Tatsuya Kondo, President, Medical Excellence JAPAN (MEJ); Honorary Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Kiyoshi Kurokawa, Professor Emeritus, Tokyo University; Professor Emeritus, National Graduate Institute for Policy Studies (GRIPS); Chairman, Health and Global Policy Institute

Kenichi Matsumoto, Chairperson, The Japan Federation of Medical Devices Associations Asahiko Mihara Member, House of Representatives (LDP)

Atsushi Mimura, Deputy Director-General, International Bureau, Ministry of Finance

Masanori Miyazaki, President, National Institute of Public Health

Nobuyuki Morishima, Vice President and Representative Director, Otsuka Pharmaceutical Co., Ltd.

Yasuhide Nakamura, Professor, School of Nursing, Konan Women’s University; President, WHO Association of Japan

Hiroki Nakatani, Project Professor, Senior Researcher, Keio Global Research Institute (KGRI), Keio University

Catherine Kaseri Ohura, Executive Director and CEO, Global Health Innovative Technology Fund (GHIT)

Shigeru Omi, President, Japan Community Healthcare Organization (JCHO); Regional Director Emeritus, World Organization for Western Pacific Region (WPRO)

Keiichi Ono, Director-General for Global Issues, Ministry of Foreign Affairs

Johtaro Seki, President, ITEC (International Total Engineering Corporation)

Yukio Takasu, Special Adviser to the Secretary-General on Human Security, UN

Satoko Itoh, Managing Director and Chief Program Officer, JCIE; Assistant Director, Friends of the Global Fund, Japan (FGFJ)

Masaaki Iuchi, Senior Assistant Minister, Ministry of Health, Labour and Welfare

Teiji Takei, Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare

Yoichi Torii, Cabinet Counsellor, Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat

Koichi Morita, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat

Fumi Yamamoto, Councilor for Pharmaceutical Affairs, Minister’s Secretariat, Ministry of Health, Labour and Welfare


Representatives of Members’ Organizations:

(alphabetical order)

Yoko Iwasaki, Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Akihiro Nagaoka, Head, Trade Associations & Regional Support, Global Public Affairs, Takeda Pharmaceutical Company Ltd.

Minori Saitoh, Vice President, Healthcare Policy & CSR, Astellas Pharma Inc.

Norio Tamura, Vice President, Government Affairs Department, Shionogi & Co., Ltd.

Aya Tokunaga, Executive Director, Policy, Advocacy & Sustainability, Eisai Co., Ltd


International & Overseas Organizations:

(alphabetical order)

Kae Ishikawa, Director, UN Women Japan Liaison Office

Takeshi Kasai, Regional Director for the Western Pacific, World Health Organization (WHO)

Mihoko Kashiwakura, Head of Japan, Bill & Melinda Gates Foundation

Yasumasa Kimura, Representative, The United Nations Children’s Fund (UNICEF) Tokyo office

Tetsuo Kondo, Director, UNDP Representation Office in Tokyo

Masato Miyazaki, Special Representative in Japan, The World Bank Group

Mariko Sato, Director, The United Nations Population Fund (UNFPA) Tokyo office